MX2009009503A - Un polipeptido de fusion para deteccion de epitopos combinatorios conservados o compuestos en proteinas no conservadas. - Google Patents

Un polipeptido de fusion para deteccion de epitopos combinatorios conservados o compuestos en proteinas no conservadas.

Info

Publication number
MX2009009503A
MX2009009503A MX2009009503A MX2009009503A MX2009009503A MX 2009009503 A MX2009009503 A MX 2009009503A MX 2009009503 A MX2009009503 A MX 2009009503A MX 2009009503 A MX2009009503 A MX 2009009503A MX 2009009503 A MX2009009503 A MX 2009009503A
Authority
MX
Mexico
Prior art keywords
conserved
combinatorial
detection
fusion polypeptide
proteins
Prior art date
Application number
MX2009009503A
Other languages
English (en)
Inventor
Saksela Kalle
Original Assignee
Next Biomed Technologies Nbt O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Next Biomed Technologies Nbt O filed Critical Next Biomed Technologies Nbt O
Publication of MX2009009503A publication Critical patent/MX2009009503A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/161—HIV-1, HIV-2 gag-pol, e.g. p55, p24/25, p17/18, p.7, p6, p66/68, p51/52, p31/34, p32, p40

Abstract

La presente invención proporciona polipéptidos de fusión de unión a epítopos múltiples para uso en un método para la detección de la presencia de virus de inmunodeficiencia humana, VIH, en una muestra biológica. La presente invención también proporciona un método para producir polipéptidos de fusión que se unen a epítopos múltiples.
MX2009009503A 2007-03-07 2008-03-07 Un polipeptido de fusion para deteccion de epitopos combinatorios conservados o compuestos en proteinas no conservadas. MX2009009503A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89342007P 2007-03-07 2007-03-07
FI20075159A FI120349B (fi) 2007-03-07 2007-03-07 Menetelmä fuusiopolypeptidin valmistamiseksi
PCT/FI2008/050111 WO2008107523A2 (en) 2007-03-07 2008-03-07 A fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins

Publications (1)

Publication Number Publication Date
MX2009009503A true MX2009009503A (es) 2010-02-17

Family

ID=37930071

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009009503A MX2009009503A (es) 2007-03-07 2008-03-07 Un polipeptido de fusion para deteccion de epitopos combinatorios conservados o compuestos en proteinas no conservadas.

Country Status (9)

Country Link
US (1) US8735328B2 (es)
EP (1) EP2129689A4 (es)
JP (1) JP2010520266A (es)
CN (1) CN101679514A (es)
AU (1) AU2008223755A1 (es)
CA (1) CA2680123A1 (es)
FI (1) FI120349B (es)
MX (1) MX2009009503A (es)
WO (1) WO2008107523A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7176724B2 (ja) 2018-07-20 2022-11-22 国立大学法人滋賀医科大学 ヒト末梢性コリン作動性神経検出用抗体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO314588B1 (no) 2000-09-04 2003-04-14 Bionor Immuno As HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
US6610472B1 (en) 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
US6833441B2 (en) 2001-08-01 2004-12-21 Abmaxis, Inc. Compositions and methods for generating chimeric heteromultimers
GB0305702D0 (en) * 2003-03-12 2003-04-16 Univ Birmingham Bispecific antibodies

Also Published As

Publication number Publication date
AU2008223755A1 (en) 2008-09-12
FI120349B (fi) 2009-09-30
CA2680123A1 (en) 2008-09-12
US20100190655A1 (en) 2010-07-29
JP2010520266A (ja) 2010-06-10
FI20075159A (fi) 2008-09-08
EP2129689A1 (en) 2009-12-09
CN101679514A (zh) 2010-03-24
FI20075159A0 (fi) 2007-03-07
WO2008107523A8 (en) 2009-07-30
EP2129689A4 (en) 2011-11-02
US8735328B2 (en) 2014-05-27
WO2008107523A2 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
WO2011100566A3 (en) Methods for identifying and isolating cells expressing a polypeptide
WO2011035202A3 (en) Universal fibronectin type iii binding-domain libraries
GB2490404B (en) Methods for determining ligand binding to a target protein using a thermal shift assay
MX337991B (es) Metodo para detectar cancer.
CA2844033C (en) Method for detecting pancreatic cancer
WO2007095350A3 (en) Compositions and methods for use of pigment epithelial derived factor (pedf) peptide fragments
MX2012004619A (es) Ensayos regulados mediante proximidad para detectar proteinas de fusion oncogenicas.
EP2535351A3 (en) Dual specificity antibody fusions
WO2005093429A3 (en) Method for the detection of intracellular parameters with luminescent protein probes for the screening of molecules capable of altering said parameters
WO2007047988A3 (en) Chimeric human sweet-umami and umami-sweet taste receptors
WO2012162373A8 (en) Ros kinase in lung cancer
WO2008095905A3 (en) Pathogen binding
WO2006091421A3 (en) Peptides for detection of antibody to ehrlichia ewingii
AU2016204135A1 (en) Screening methods for transfusion related acute lung injury (TRALI)
WO2009033163A3 (en) Borrelia diagnostics and screening methods
IL223077A0 (en) Novel as160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics
WO2008060483A3 (en) Protein-protein interaction biosensors and methods of use thereof
MX353464B (es) Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles.
WO2006053251A3 (en) Method of measuring amyloid-beta peptides
EP2670755A1 (en) Trifunctional crosslinking reagents
EP2161284A4 (en) CITRULLINED FIBRIN-FILAGRIN RECOMBINANT POLYPEPTIDE CAPABLE OF DETECTING ANTIBODIES GENERATED IN RHEUMATOID ARTHRITIS
WO2009143098A3 (en) Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
WO2009086125A3 (en) Affinity tag nucleic acid and protein compositions, and processes for using same
WO2010009856A3 (en) Goodpasture antigen binding protein and its detection
MX2009009503A (es) Un polipeptido de fusion para deteccion de epitopos combinatorios conservados o compuestos en proteinas no conservadas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal